BioMarin Pharmaceutical Inc. (BM8.F) Stock Price, News & Chart

	BM8.F	BBIO	1952.HK	IONS	0NZU.IL	KRYS
Market cap	9.85B	15.17B	9.83B	6.67B	14.40B	9.21B
P/E (TTM)	—	—	—	—	—	42.2
Forward P/E	55.3	-225.0	20.4	-35.0	—	34.0
Price/book	1.8	-5.9	1.3	15.1	8.1	6.4
Dividend yield	—	—	—	—	—	—
1-year change	+7.99%	+24.17%	−44.53%	−45.82%	−43.38%	+55.44%
Today	+3.10%	+5.21%	+5.06%	−0.67%	+1.30%	+1.90%

Market cap

9.85B

15.17B

9.83B

6.67B

14.40B

9.21B

P/E (TTM)

—

42.2

Forward P/E

55.3

-225.0

20.4

-35.0

—

34.0

Price/book

1.8

-5.9

1.3

15.1

8.1

6.4

Dividend yield

—

1-year change

+7.99%

+24.17%

−44.53%

−45.82%

−43.38%

+55.44%

Today

+3.10%

+5.21%

+5.06%

−0.67%

+1.30%

+1.90%

Company	Mkt cap	Price	Today
BridgeBio Pharma, Inc.BBIO · Biotechnology	15.17B	77.89	+5.21%
Everest Medicines Limited1952.HK · Biotechnology	9.83B	27.800	+5.06%
Ionis Pharmaceuticals, Inc.IONS · Biotechnology	6.67B	40.15	−0.67%
Zealand Pharma A/S0NZU.IL · Biotechnology	14.40B	241.45	+1.30%
Krystal Biotech, Inc.KRYS · Biotechnology	9.21B	310.84	+1.90%
BrightGene Bio-Medical Technology Co., Ltd.688166.SS · Biotechnology	13.81B	31.70	+2.42%
Ultragenyx Pharmaceutical Inc.RARE · Biotechnology	1.69B	17.16	+3.19%
Ligand Pharmaceuticals IncorporatedLGND · Biotechnology	6.32B	316.13	+0.83%

Company	Mkt cap	Price	Today
Financière de Tubize SAFTD.F · Brussels, Belgium	10.23B	229.80	+1.68%
Ascentage Pharma Group International6855.HK · Suzhou, China	11.30B	30.240	+6.70%
Inner Mongolia Furui Medical Science Co., Ltd.300049.SZ · Beijing, China	13.02B	49.32	+20.00%
Apogee Therapeutics IncAPGE · San Francisco, CA	10.22B	135.07	0.00%
Nuvalent IncNUVL · Cambridge, MA	9.81B	123.96	0.00%
Sino Biopharmaceutical LimitedSMZ1.F · Wan Chai, Hong Kong	11.09B	0.6235	+1.45%
Vaxcyte, Inc.PCVX · San Carlos, CA	10.34B	65.68	+8.01%
Chengdu Olymvax Biopharmaceuticals Inc.688319.SS · Chengdu, China	12.12B	29.90	+6.03%

Company	Mkt cap	Price	Today
Xi'an International Medical Investment Company Limited000516.SZ · Medical Care Facilities	10.55B	4.7100	+2.84%
Financière de Tubize SAFTD.F · Biotechnology	10.23B	229.80	+1.68%
Ascentage Pharma Group International6855.HK · Biotechnology	11.30B	30.240	+6.70%
Sinocare Inc.300298.SZ · Medical Devices	10.60B	19.03	+1.55%
Bio-Rad Laboratories, Inc.BIO · Medical Devices	10.16B	379.99	+1.35%
Oscar Health, Inc.OSCR · Healthcare Plans	10.86B	35.19	+8.58%
Bausch + Lomb CorporationBLCO.TO · Medical Instruments & Supplies	10.29B	28.77	+2.82%
Lincoln Pharmaceuticals LimitedLINCOLN.NS · Drug Manufacturers - Specialty & Generic	10.27B	512.55	+0.43%

Company	Mkt cap	Price	Today
Westamerica BancorporationWABC · San Rafael, CA	1.41B	61.28	+1.49%
NVIDIA CorporationNVDA · Santa Clara, CA Odds	4.83T	200.13	−3.17%
Apple Inc.AAPL · Cupertino, CA Odds	5.08T	349.51	+5.31%
Meta Platforms, Inc.META.BA · Menlo Park, CA	112.71T	44,080.00	+1.99%
Broadcom Inc.AVGOCL.SN · Palo Alto, CA	1,519.49T	318,310.00	0.00%
The Walt Disney CompanyDISN.BA · Burbank, CA	228.48T	16,540.00	+4.16%
Advanced Micro Devices, Inc.AMD.BA · Santa Clara, CA	133.29T	81,650.00	+0.71%
Adobe Inc.ADBECL.SN · San Jose, CA	94.53T	242,890.00	+4.81%

Company	Mkt cap	Price	Today
OraSure Technologies, Inc.OSUR · government · life sciences · healthcare	256.56M	3.7200	+5.38%
Bio-Rad Laboratories, Inc.BIO · government · life sciences · healthcare	10.16B	379.99	+1.35%
Organon & Co.OGN · government · healthcare	3.63B	13.83	−0.14%
Revvity, Inc.RVTY · government · life sciences · healthcare	17.79B	159.43	−2.48%
Bristol-Myers Squibb CompanyBMY · government · life sciences · healthcare	131.21B	64.19	+4.02%
Pfizer Inc.PFE.NE · government · life sciences · healthcare	237.39B	13.65	+2.55%
Biocon LimitedBIOCON.NS · government · life sciences	592.87B	362.00	+5.10%
Clarivate PlcCLVT · government · life sciences · healthcare	1.36B	2.1200	+1.44%

Company	Mkt cap	Price	Today
Incyte CorporationICY.F · Correlation 0.38	22.13B	108.55	+4.83%
Sarepta Therapeutics, Inc.AB3A.F · Correlation 0.37	1.76B	16.62	+2.34%

Company	Mkt cap	Price	Today
Incyte Corp.ICY.F	22.13B	108.55	+4.83%
Alnylam Pharmaceuticals IncDUL.F	19.44B	145.15	+0.07%
Bio-Techne Corp.TE1.F	9.93B	63.22	−0.97%
VERTEX PHARMACEUTICALS INC.VX1.F	122.76B	484.35	−0.51%
Sarepta Therapeutics Inc.AB3A.F	1.76B	16.62	+2.34%

TradingView·1d agoNegative

BioMarin Pharmaceutical Inc. Stock 12‑Month Price Target Cut to $90.85, Implies 58% Upside

TradingView BioMarin Pharmaceutical Inc. Stock 12‑Month Price Target Cut to $90.85, Implies 58% Upside - According to estimates from 26 analysts, BioMarin Pharmaceutical Inc. stock's average price target has

BMRN BIIB MS AVBP

Markets Daily·1d agoNegative

BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Target Lowered at Morgan Stanley

Posted by Sarita Garza on Nov 3rd, 2026 Get Our Latest Analysis on BMRN Here are the key news stories impacting BioMarin Pharmaceutical this week: BioMarin Pharmaceutical Inc is a biotechnology company focused on developing and…

BMRN MS BIIB

Markets Daily·1d agoPositive

HC Wainwright Reaffirms Neutral Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)

Posted by Kim Johansen on Nov 3rd, 2026 BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “neutral” rating reaffirmed by investment analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports.…

BMRN CBIO URGN

Markets Daily·1d agoNegative

BioMarin Pharmaceutical (NASDAQ:BMRN) Issues FY 2026 Earnings Guidance

Posted by Sarita Garza on Nov 3rd, 2026 BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 2.800-3.100 for the period, compared to the consensus…

BMRN BMY

The Globe and Mail·2d agoNegative

Robert W. Baird Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)

In a report released yesterday, Jack Allen from Robert W. Baird maintained a Hold rating on BioMarin Pharmaceutical, with a price target of $65.00. The company’s shares closed yesterday at $55.35. According to TipRanks, Allen is an analyst…

BMRN BIIB

Seeking Alpha·2d ago·2 outletsPositive

BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST Traci McCarty - Group Vice PresidentAlexander Hardy - President, CEO & DirectorCristin Hubbard - Executive VP & Chief Commercial OfficerGregory Friberg…

BMRN GS BAC

BioMarin Pharmaceutical Non-GAAP EPS of $0.23 beats by $0.34, revenue of $1.03B beats by $10M

BioMarin Q3 earnings topped estimates on EPS and revenue as sales jumped 32%. - BioMarin Pharmaceutical press release (BMRN): Q3 Non-GAAP EPS of $0.23 beats by $0.34. - Revenue of $1.03B (+32.7% Y/Y) beats by $10M. - Third Quarter 2026…

BMRN BIIB

TradingView·2d agoPositive

BioMarin Pharmaceutical (NASDAQ:BMRN) reports Q3 2026 in line with expectations but full-year sales guidance misses expectations

Biotech company BioMarin Pharmaceutical BMRNmet Wall Street’s revenue expectations in Q3 2026, with revenue up 32% year on year to $1.02 billion. On the other hand, the company’s full-year revenue guidance of $3.85 billion at the midpoint…

BMRN BMY BIIB

@_AlphaStreet·Oct 26Positive

BioMarin Pharmaceutical (BMRN): Amicus Acquisition Accelerates Revenue Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has entered a transformational phase following its $4.8 billion all-cash acquisition of Amicus Therapeutics, completed... The post BioMarin Pharmaceutical (BMRN): Amicus Acquisition Accelerates…

BMRN BMY AZN

The Globe and Mail·Oct 21

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Eli Lilly & Co (LLY) and Bristol-Myers Squibb (BMY)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN), Eli Lilly & Co (LLY) and Bristol-Myers Squibb (BMY). Wells Fargo analyst Mohit Bansal assigned a Buy rating to…

LLY BMY NAMS

Days on the list

30 d

1 yr

Best

Trending

—

Install

BioMarin Pharmaceutical Inc.

Key statistics

Against its peers

Latest news